Acorah Software Products - Accounts Production 19.2.450 false true 30 April 2025 24 April 2024 false true No description of principal activity 1 May 2025 30 April 2026 30 April 2026 15674743 B Akay iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15674743 2025-04-30 15674743 2026-04-30 15674743 2025-05-01 2026-04-30 15674743 frs-core:CurrentFinancialInstruments 2026-04-30 15674743 frs-bus:PrivateLimitedCompanyLtd 2025-05-01 2026-04-30 15674743 frs-bus:FilletedAccounts 2025-05-01 2026-04-30 15674743 frs-bus:Micro-entities 2025-05-01 2026-04-30 15674743 frs-bus:AuditExempt-NoAccountantsReport 2025-05-01 2026-04-30 15674743 frs-bus:Director1 2025-05-01 2026-04-30 15674743 2024-04-23 15674743 2025-04-30 15674743 2024-04-24 2025-04-30 15674743 frs-core:CurrentFinancialInstruments 2025-04-30
Registered number: 15674743
Angel Pharma Ltd
Unaudited Financial Statements
For The Year Ended 30 April 2026
M.R Accountants Ltd
Balance Sheet
Registered number: 15674743
2026 2025
£ £
Current assets 5,925 5,219
Creditors: Amounts Falling Due Within One Year (3,948 ) (5,070 )
NET CURRENT ASSETS 1,977 149
TOTAL ASSETS LESS CURRENT LIABILITIES 1,977 149
NET ASSETS 1,977 149
CAPITAL AND RESERVES 1,977 149

Notes

1. General Information
Angel Pharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15674743 . The registered office is 9b The Broadway, Woodford Green, IG8 0HL.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2025: NIL)
1 -
For the year ending 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
B Akay
Director
19/08/2026